hematological tumors
Showing 1 - 25 of >10,000
Hematological Tumors Trial in Beijing (TQB2825 injection)
Recruiting
- Hematological Tumors
- TQB2825 injection
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 4, 2022
Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for
Completed
- Relapsed or Refractory Non-Hodgkin's Lymphoma
- Relapsed or Refractory Multiple Myeloma
- BEBT-908 for injection
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Oct 9, 2023
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)
Recruiting
- Lymphoma, B-Cell
- +3 more
- CAR-T
-
Cangzhou, Hebei, ChinaCangzhou People's Hospital
Nov 9, 2022
Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)
Not yet recruiting
- Hematological Malignancy
- Solid Tumor
- OT-A201
- +4 more
- (no location specified)
Apr 24, 2023
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)
Active, not recruiting
- Hematologic Neoplasm
- Neoplasms
-
Gainesville, Florida
- +2 more
Jan 12, 2023
Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)
Not yet recruiting
- Advanced Solid Tumors
- Hematological Malignancies
- (no location specified)
Apr 14, 2022
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease Trial in Jinan (Micafungin Sodium)
Recruiting
- Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
- Micafungin Sodium
-
Jinan, Shandong, ChinaDepartment of Hematology, Provincial Hospital Affiliated to Shan
Feb 1, 2021
Tissue Specimens From Solid Tumors or Blood Disorders and Their
Recruiting
- Neoplasms
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination
Active, not recruiting
- Pediatric Cancer
- +2 more
- Durvalumab / Tremelimumab Combination Therapy
-
Baltimore, Maryland
- +18 more
Nov 3, 2022
Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)
Completed
- Solid Tumors
- Hematological Malignancies
- Belinostat IV
-
Santa Monica, California
- +2 more
Sep 10, 2021
Advanced Solid Tumors and Hematological Malignancies Trial (TQB2928 Injection)
Not yet recruiting
- Advanced Solid Tumors and Hematological Malignancies
- TQB2928 Injection
- (no location specified)
Apr 21, 2021
Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)
Completed
- Advanced Solid and Hematological TP53wt Tumors
- HDM201
- ancillary treatment
-
Boston, Massachusetts
- +14 more
May 20, 2021
Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)
Recruiting
- Solid Tumor
- Hematologic Malignancy
- Eliglustat
- Immune checkpoint inhibitor
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Apr 28, 2022
Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)
Completed
- Hematological Disease
- +5 more
- Total Body Irradiation 1200 cGy
- +9 more
-
Rochester, New YorkWilmot Cancer Institute
Nov 1, 2021
T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- +3 more
- Universal CD7-specific CAR gene-engineered T cells
-
Beijing, Beijing, China
- +2 more
Aug 17, 2023
Prevelance Of Cutaneous Disorders Among Heamatologic
Not yet recruiting
- Dermatologic Disorders With Heamatologic Malignancies Patients
- cbc ,u\s renalor hepatic function test if needed
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Solid Tumor, Adult
- CD70-targeting CAR-T cells
-
Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 8, 2023
B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)
Recruiting
- B Cell Malignancies
- Universal CD19-specific CAR gene-engineered T cells
-
Beijing, Beijing, China
- +2 more
Aug 8, 2023
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Relapsed/Refractory Solid Tumors/Hematological Malignancies Trial in Whittier, Canton (Belinostat)
Terminated
- Relapsed/Refractory Solid Tumors/Hematological Malignancies
-
Whittier, California
- +1 more
Nov 18, 2019
Safety of ABCD in the Treatment of IFD
Recruiting
- Invasive Fungal Disease
- Amphotericin B colloidal dispersion（ABCD）
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 20, 2022
Solid Tumor Trial (BS006 Injection)
Not yet recruiting
- Solid Tumor
- BS006 Injection
- (no location specified)
Jul 3, 2023